Selected research
Industry Research
Labeled Nucleotides Industry Research Report 2026
Market perspective
The global Labeled Nucleotides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Labeled Nucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Labeled Nucleotides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Labeled Nucleotides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Labeled Nucleotides include ThermoFisher Scientific, Nanjing BioTogether, F. Hoffmann-La Roche, Yumpu, Star Lake Bioscience, Promega Corporation, Meihua Group, Lallemand and Jena Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Labeled Nucleotides market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Labeled Nucleotides Market by Company
ThermoFisher Scientific
Nanjing BioTogether
F. Hoffmann-La Roche
Yumpu
Star Lake Bioscience
Promega Corporation
Meihua Group
Lallemand
Jena Bioscience
DSM Nutritional Products
CJ CheilJedang Corporation
Biorigin
Agilent Technologies
Affymetrix
Labeled Nucleotides Segment by Type
Gene Chips & Microarrays
SNP by Pyrosequencing
TaqMan Allelic Discrimination
Labeled Nucleotides Segment by Application
Hospital Laboratories
Academic Research Laboratories
Reference Laboratories
Other Laboratories
Labeled Nucleotides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Labeled Nucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Labeled Nucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Labeled Nucleotides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Labeled Nucleotides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Labeled Nucleotides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Labeled Nucleotides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Chips & Microarrays
- SNP by Pyrosequencing
- TaqMan Allelic Discrimination
Applications
- Hospital Laboratories
- Academic Research Laboratories
- Reference Laboratories
- Other Laboratories
Companies covered
- ThermoFisher Scientific
- Nanjing BioTogether
- F. Hoffmann-La Roche
- Yumpu
- Star Lake Bioscience
- Promega Corporation
- Meihua Group
- Lallemand
- Jena Bioscience
- DSM Nutritional Products
- CJ CheilJedang Corporation
- Biorigin
- Agilent Technologies
- Affymetrix
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Labeled Nucleotides Market Size (2021-2032)
- 2.2.2 Global Labeled Nucleotides Sales (2021-2032)
- 2.2.3 Global Labeled Nucleotides Market Average Price (2021-2032)
- 2.3 Labeled Nucleotides by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gene Chips & Microarrays
- 2.3.3 SNP by Pyrosequencing
- 2.3.4 TaqMan Allelic Discrimination
- 2.4 Labeled Nucleotides by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Laboratories
- 2.4.3 Academic Research Laboratories
- 2.4.4 Reference Laboratories
- 2.4.5 Other Laboratories
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Labeled Nucleotides Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Labeled Nucleotides Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Labeled Nucleotides Revenue of Manufacturers (2021-2026)
- 3.4 Global Labeled Nucleotides Average Price by Manufacturers (2021-2026)
- 3.5 Global Labeled Nucleotides Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Labeled Nucleotides, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Labeled Nucleotides, Product Type & Application
- 3.8 Global Manufacturers of Labeled Nucleotides, Established Date
- 3.9 Global Labeled Nucleotides Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ThermoFisher Scientific
- 4.1.1 ThermoFisher Scientific Company Information
- 4.1.2 ThermoFisher Scientific Business Overview
- 4.1.3 ThermoFisher Scientific Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ThermoFisher Scientific Labeled Nucleotides Product Portfolio
- 4.1.5 ThermoFisher Scientific Recent Developments
- 4.2 Nanjing BioTogether
- 4.2.1 Nanjing BioTogether Company Information
- 4.2.2 Nanjing BioTogether Business Overview
- 4.2.3 Nanjing BioTogether Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nanjing BioTogether Labeled Nucleotides Product Portfolio
- 4.2.5 Nanjing BioTogether Recent Developments
- 4.3 F. Hoffmann-La Roche
- 4.3.1 F. Hoffmann-La Roche Company Information
- 4.3.2 F. Hoffmann-La Roche Business Overview
- 4.3.3 F. Hoffmann-La Roche Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 F. Hoffmann-La Roche Labeled Nucleotides Product Portfolio
- 4.3.5 F. Hoffmann-La Roche Recent Developments
- 4.4 Yumpu
- 4.4.1 Yumpu Company Information
- 4.4.2 Yumpu Business Overview
- 4.4.3 Yumpu Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yumpu Labeled Nucleotides Product Portfolio
- 4.4.5 Yumpu Recent Developments
- 4.5 Star Lake Bioscience
- 4.5.1 Star Lake Bioscience Company Information
- 4.5.2 Star Lake Bioscience Business Overview
- 4.5.3 Star Lake Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Star Lake Bioscience Labeled Nucleotides Product Portfolio
- 4.5.5 Star Lake Bioscience Recent Developments
- 4.6 Promega Corporation
- 4.6.1 Promega Corporation Company Information
- 4.6.2 Promega Corporation Business Overview
- 4.6.3 Promega Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Promega Corporation Labeled Nucleotides Product Portfolio
- 4.6.5 Promega Corporation Recent Developments
- 4.7 Meihua Group
- 4.7.1 Meihua Group Company Information
- 4.7.2 Meihua Group Business Overview
- 4.7.3 Meihua Group Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Meihua Group Labeled Nucleotides Product Portfolio
- 4.7.5 Meihua Group Recent Developments
- 4.8 Lallemand
- 4.8.1 Lallemand Company Information
- 4.8.2 Lallemand Business Overview
- 4.8.3 Lallemand Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lallemand Labeled Nucleotides Product Portfolio
- 4.8.5 Lallemand Recent Developments
- 4.9 Jena Bioscience
- 4.9.1 Jena Bioscience Company Information
- 4.9.2 Jena Bioscience Business Overview
- 4.9.3 Jena Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jena Bioscience Labeled Nucleotides Product Portfolio
- 4.9.5 Jena Bioscience Recent Developments
- 4.10 DSM Nutritional Products
- 4.10.1 DSM Nutritional Products Company Information
- 4.10.2 DSM Nutritional Products Business Overview
- 4.10.3 DSM Nutritional Products Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 DSM Nutritional Products Labeled Nucleotides Product Portfolio
- 4.10.5 DSM Nutritional Products Recent Developments
- 4.11 CJ CheilJedang Corporation
- 4.11.1 CJ CheilJedang Corporation Company Information
- 4.11.2 CJ CheilJedang Corporation Business Overview
- 4.11.3 CJ CheilJedang Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CJ CheilJedang Corporation Labeled Nucleotides Product Portfolio
- 4.11.5 CJ CheilJedang Corporation Recent Developments
- 4.12 Biorigin
- 4.12.1 Biorigin Company Information
- 4.12.2 Biorigin Business Overview
- 4.12.3 Biorigin Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Biorigin Labeled Nucleotides Product Portfolio
- 4.12.5 Biorigin Recent Developments
- 4.13 Agilent Technologies
- 4.13.1 Agilent Technologies Company Information
- 4.13.2 Agilent Technologies Business Overview
- 4.13.3 Agilent Technologies Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Agilent Technologies Labeled Nucleotides Product Portfolio
- 4.13.5 Agilent Technologies Recent Developments
- 4.14 Affymetrix
- 4.14.1 Affymetrix Company Information
- 4.14.2 Affymetrix Business Overview
- 4.14.3 Affymetrix Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Affymetrix Labeled Nucleotides Product Portfolio
- 4.14.5 Affymetrix Recent Developments
5 Global Labeled Nucleotides Market Scenario by Region
- 5.1 Global Labeled Nucleotides Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Labeled Nucleotides Sales by Region: 2021-2032
- 5.2.1 Global Labeled Nucleotides Sales by Region: 2021-2026
- 5.2.2 Global Labeled Nucleotides Sales by Region: 2027-2032
- 5.3 Global Labeled Nucleotides Revenue by Region: 2021-2032
- 5.3.1 Global Labeled Nucleotides Revenue by Region: 2021-2026
- 5.3.2 Global Labeled Nucleotides Revenue by Region: 2027-2032
- 5.4 North America Labeled Nucleotides Market Facts & Figures by Country
- 5.4.1 North America Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Labeled Nucleotides Sales by Country (2021-2032)
- 5.4.3 North America Labeled Nucleotides Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Labeled Nucleotides Market Facts & Figures by Country
- 5.5.1 Europe Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Labeled Nucleotides Sales by Country (2021-2032)
- 5.5.3 Europe Labeled Nucleotides Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Labeled Nucleotides Market Facts & Figures by Country
- 5.6.1 Asia Pacific Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Labeled Nucleotides Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Labeled Nucleotides Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Labeled Nucleotides Market Facts & Figures by Country
- 5.7.1 South America Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Labeled Nucleotides Sales by Country (2021-2032)
- 5.7.3 South America Labeled Nucleotides Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Labeled Nucleotides Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Labeled Nucleotides Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Labeled Nucleotides Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Labeled Nucleotides Sales by Type (2021-2032)
- 6.1.1 Global Labeled Nucleotides Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Labeled Nucleotides Sales Market Share by Type (2021-2032)
- 6.2 Global Labeled Nucleotides Revenue by Type (2021-2032)
- 6.2.1 Global Labeled Nucleotides Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Labeled Nucleotides Revenue Market Share by Type (2021-2032)
- 6.3 Global Labeled Nucleotides Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Labeled Nucleotides Sales by Application (2021-2032)
- 7.1.1 Global Labeled Nucleotides Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Labeled Nucleotides Sales Market Share by Application (2021-2032)
- 7.2 Global Labeled Nucleotides Revenue by Application (2021-2032)
- 7.2.1 Global Labeled Nucleotides Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Labeled Nucleotides Revenue Market Share by Application (2021-2032)
- 7.3 Global Labeled Nucleotides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Labeled Nucleotides Value Chain Analysis
- 8.1.1 Labeled Nucleotides Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Labeled Nucleotides Production Mode & Process
- 8.2 Labeled Nucleotides Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Labeled Nucleotides Distributors
- 8.2.3 Labeled Nucleotides Customers
9 Global Labeled Nucleotides Analyzing Market Dynamics
- 9.1 Labeled Nucleotides Industry Trends
- 9.2 Labeled Nucleotides Industry Drivers
- 9.3 Labeled Nucleotides Industry Opportunities and Challenges
- 9.4 Labeled Nucleotides Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst